Study for evaluating efficacy and safety of TACE with miriplatin in the treatment of patients with hepatocellular carcinoma

Trial Profile

Study for evaluating efficacy and safety of TACE with miriplatin in the treatment of patients with hepatocellular carcinoma

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 04 Aug 2014

At a glance

  • Drugs Miriplatin (Primary) ; Epirubicin
  • Indications Liver cancer
  • Focus Therapeutic Use
  • Acronyms MELT
  • Most Recent Events

    • 09 May 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top